Lyka Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve 1. To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the 2nd quarter and six months ended 30th September 2025 alongwith Limited Review Report issued by Statutory Auditor of the Company2. To consider and approve shifting of the Registered Office of the Company from State of Gujarat to Maharashtra3. To consider and approve Notice of Extra-Ordinary General Meeting of the Company4. Any other Business
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]